Mass cytometry publications trending now

New models for dynamic signaling networks involving genes, proteins and other molecules continue to be developed as we learn more about the complexity of diverse cell populations and their interactions. Research into and development of new methods using CyTOF^® technology help to enhance how we can discover key targets in drug development and better grasp specific disease signatures. Here, Fluidigm looks at new perspectives on the roles that signaling molecules play in health and disease.